Document is current
Any future updates will be listed below
-
Authors
Zhang, Difei
Peng, Yu
Zheng, Tingting
Liu, Hui
Wu, Jianfeng
Li, Zewen
Su, Jingxu
Xu, Yuan
Hu, Xiaoxuan
Chen, Guowei
Hou, Haijing
Zhang, La
Wu, Liwen
Liu, Xusheng
Lu, Fuhua
-
Funding
Funding for this research was provided by:
Construction of National Specialized Diagnosis and Treatment Center of Regional Traditional Chinese Medicine (0103020802)
Pilot Construction of Clinical Collaboration between Chinese and Western Medicine in Major and Refractory Disease (0103020603)
- License Information
-
More Information
Article History
Received: 21 August 2019
Accepted: 7 July 2020
First Online: 20 July 2020
Ethics approval and consent to participate
: The study protocol was consistent with the ethical principles of the Helsinki and was approved by the Institutional Ethics Review Boards of Guangdong Provincial Hospital of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine (ZE2019014–01). All patients were asked for permission to use their medical data for a non-commercial research, and provided their written informed consent at the initiation of PD follow-up.
: Not applicable.
: The authors declare that they have no conflicts of interest.
